LIVZON PHARMA Publishes 2026 Q3 Report, Calls Second EGM and Unveils 2026-2028 Shareholder Return Plan

Bulletin Express
10/23

On 23 October 2026, Hong Kong-listed Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) released a package of corporate documents comprising:

• 2026 Third Quarterly Report • Circular dated 23 October 2026 • Notice and Proxy Form for the 2026 Second Extraordinary General Meeting (EGM) • Profit Distribution Proposal for the Third Quarter of 2026 • Shareholder Return Plan for 2026-2028

All materials are now available in both English and Chinese on the company’s website (www.livzon.com.cn) and on the Hong Kong Stock Exchange website (www.hkexnews.hk).

Shareholders whose holdings are maintained through CCASS and other intermediaries may register an e-mail address with their broker, bank, custodian, or nominee to receive electronic notifications when future corporate communications are published. Those unable to access the online versions can obtain printed copies free of charge by submitting the enclosed request form to Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by e-mailing 1513-ecom@vistra.com.

The company secretary, Liu Ning, signed the notification on behalf of the board. For enquiries, shareholders may contact Tricor’s hotline at +852 2980 1333 during business hours, Monday to Friday (excluding public holidays).

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10